MASP interactions with plasma-derived MBL

Molecular Immunology

Volumn 52, Issue 2, 2012, Pages 79-87

  Laursen, Inga A ^a   Thielens, Nicole M ^b,c,d   Christiansen, Michael ^a   Houen, Gunnar ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b CEA GRENOBLE   (France)

^c CNRS   (France)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

Exchange; MASP; MBL; Plasma; Recombinant protein

Indexed keywords

MANNAN BINDING LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 3; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

BINDING, COMPETITIVE; COMPLEMENT ACTIVATION; HUMANS; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; RECOMBINANT PROTEINS;

EID: 84861656156     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.04.014     Document Type: Article

References (50)

1. Ambrus G., Gal P., Kojima M., Szilágyi K., Balczer J., Antal J., Gráf L., Laich A., Moffatt B.E., Schwaeble W., Sim R.B., Závodszky P. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. Journal of Immunology 2003, 170:1374-1382.
2. Bang P., Laursen I., Thornberg K., Schierbeck J., Nielsen B., Valdimarsson H., Koch C., Christiansen M. The pharmacokinetic profile of plasma-derived mannan-binding lectin in healthy adult volunteers and patients with Staphylococcus aureus septicaemia. Scandinavian Journal of Infectious Diseases 2008, 40:44-48.
3. Bergmann J., Christiansen M., Laursen I., Bang P., Hansen N.E., Ellegaard J., Koch C., Andersen V. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. European Journal of Haematology 2003, 70:91-97.
4. Bitsch M., Laursen I., Engel A.-M., Christiansen M., Larsen S.O., Iversen L., Holstein P.E., Karlsmark T. Epidemiology of chronic wound patients and relation to serum levels of mannan-binding lectin. Acta Dermato-Venereologica 2009, 89:607-611.
5. Bitsch M., Christiansen M., Laursen I., Engel A.-M., Holstein P.E., Jørgensen B., Karlsmark T. Is there a connection between MBL and chronic ulcers?. Acta Dermato-Venereologica 2009, 89:307-308.
6. Brouwer N., Frakking F.N., van de Wetering M.D., van Houdt M., Hart M., Budde I.K., Strengers P.F., Laursen I., Houen G., Roos D., Jensenius J.C., Caron H.N., Dolman K.M., Kuijpers T.W. Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels. Journal of Immunology 2009, 183:3496-3504.
7. Dahl M.R., Thiel S., Matsushita M., Fujita T., Willis A.C., Christensen T., Vorup-Jensen T., Jensenius J.C. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 2001, 15:127-135.
8. Degn S.E., Hansen A.G., Steffensen R., Jacobsen C., Jensenius J.C., Thiel S. MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. Journal of Immunology 2009, 183:7371-7378.
9. Degn S.E., Jensenius J.C., Bjerre M. The lectin pathway and its implications in coagulation, infections and auto-immunity. Current Opinion in Organ Transplantation 2011, [Epub ahead of print].
10. Dommett R.M., Klein N., Turner M.W. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 2006, 68:193-209.
11. Eisen D.P., Dean M.M., Thomas P., Marshall P., Gerns N., Heatley S., Quinn J., Minchinton R.M., Lipman J. Low mannose-binding lectin function is associated with sepsis in adult patients. FEMS Immunology and Medical Microbiology 2006, 48:274-282.
12. Frakking F.N., Brouwer N., van de Wetering M.D., Budde I.K., Strengers P.F., Huitema A.D., Laursen I., Houen G., Caron H.N., Dolman K.M., Kuijpers T.W. Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substituted in children with chemotheraphy-induced neutropaenia. European Journal of Cancer 2009, 45:505-512.
13. Fraser D.A., Bohlson S.S., Jasinskiene N., Rawal N., Palmarini G., Ruiz S., Rochford R., Tenner A.J. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. Journal of Leukocyte Biology 2006, 80:107-116.
14. Garred P., Pressler T., Lanng S., Madsen H.O., Moser C., Laursen I., Balstrup F., Koch C., Koch C. Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatric Pulmonology 2002, 33:201-207.
15. Gingras A.R., Girija U.V., Keeble A.H., Panchal R., Mitchell D.A., Moody P.C., Wallis R. Structural basis of mannan-binding lectin recognition by its associated serine protease MASP-1: implications for complement activation. Structure 2011, 19:1635-1643.
16. Gregory L.A., Thielens N.M., Matsushita M., Sorensen R., Arlaud G.J., Fontecilla-Camps J.C., Gaboriaud C. The X-ray structure of human mannan-binding lectin-associated protein 19 (MAp19) and its interaction site with mannan-binding lectin and l-ficolin. Journal of Biological Chemistry 2004, 279:29391-29397.
17. Jensen P.H., Weilguny D., Matthiesen F., Mcguire K.A., Shi L., Hojrup P. Characterization of the oligomer structure of recombinant human mannan-binding lectin. Journal of Biological Chemistry 2005, 280:11043-11051.
18. Kerr F.K., Thomas A.R., Wijeyewickrema L.C., Whisstock J.C., Boyd S.E., Kaiserman D., Matthews A.Y., Bird P.I., Thielens N.M., Rossi V., Pike R.N. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor. Molecular Immunology 2008, 45:670-677.
19. Kilpatrick D.C. Mannan-binding lectin: clinical significance and applications. Biochimica et Biophysica Acta 2002, 1572:401-413.
20. Krarup A., Wallis R., Presanis J.S., Gal P., Sim R.B. Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One 2007, 2:e623.
21. Lacroix M., Dumestre-Perard C., Schoehn G., Houen G., Cesbron J.Y., Arlaud G.J., Thielens N.M. Residue Lys57 in the collagen-like region of human l-ficolin and its counterpart Lys47 in H-ficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin. Journal of Immunology 2009, 182:456-465.
22. Laursen I. Mannan-binding lectin (MBL) production from human plasma. Biochemical Society Transactions 2003, 31:758-762.
23. Laursen I., Houen G., Højrup P., Brouwer N., Krogsøe L.B., Blou L., Hansen P.R. Second-generation nanofiltered mannan-binding lectin product from plasma. Vox Sanguinis 2007, 92:338-350.
24. Laursen I., Højrup P., Houen G., Christiansen M. Characterisation of the 1st SSI purified MBL standard. Clinica Chimica Acta 2008, 395:159-161.
25. Madsen H.O., Garred P., Thiel S., Kurtzhals J.A., Lamm L.U., Ryder L.P., Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. Journal of Immunology 1995, 155:3013-3020.
26. Matsushita M., Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. Journal of Experimental Medicine 1992, 176:1497-1502.
27. Matsushita M., Thiel S., Jensenius J.C., Terai I., Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine proteases. Journal of Immunology 2000, 165:2637-2642.
28. Moller-Kristensen M., Jensenius J.C., Jensen L., Thielens N., Rossi V., Arlaud G., Thiel S. Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. Journal of Immunological Methods 2003, 282:159-167.
29. Munthe-Fog L., Hummelshoj T., Honore C., Madsen H.O., Permin H., Garred P. Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. New England Journal of Medicine 2009, 360:2637-2644.
30. Petersen S.V., Thiel S., Jensen L., Steffensen R., Jensenius J.C. An assay for the mannan-binding lectin pathway of complement activation. Journal of Immunological Methods 2001, 257:107-116.
31. Phillips A.E., Toth J., Dodds A.W., Girija U.V., Furze C.M., Pala E., Sim R.B., Reid K.B., Schwaeble W.J., Schmid R., Keeble A.H., Wallis R. Analogous interactions in initiating complexes of the classical and lectin pathways of complement. Journal of Immunology 2009, 182:7708-7717.
32. Saevarsdottir S., Kristjansdottir H., Grondal G., Vikingsdottir T., Gudnason V., Valdimarsson H. Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosus. Annals of the Rheumatic Diseases 2006, 65:1462-1467.
33. Skjoedt M.O., Hummelshoj T., Palarasah Y., Honore C., Koch C., Skjodt K., Garred P. A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. Journal of Biological Chemistry 2010, 285:8234-8243.
34. Skjoedt M.O., Palarasah Y., Munthe-Fog L., Jie Ma Y., Weiss G., Skjodt K., Koch C., Garred P. MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with ficolin-3 and regulates ficolin-3 mediated complement activation. Immunobiology 2010, 215:921-931.
35. Stover C.M., Thiel S., Thelen M., Lynch N.J., Vorup-Jensen T., Jensenius J.C., Schwaeble W.J. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. Journal of Immunology 1999, 162:3481-3490.
36. Super M., Lu J., Thiel S., Levinsky R.T., Turner M.W. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989, 334:1236-1239.
37. Takahashi K., Chang W.C., Takahashi M., Pavlov V., Ishida Y., La Bonte L., Shi L., Fujita T., Stahl G.L., Van Cott E.M. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology 2011, 216:96-102.
38. Takahashi M., Endo Y., Fujita T., Matsushita M. A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. International Immunology 1999, 11:859-863.
39. Tateishi K., Kanemoto T., Fujita T., Matsushita M. Characterization of the complex between mannose-binding lectin trimer and mannose-binding lectin-associated serine proteases. Microbiology and Immunology 2011, 55:427-433.
40. Teillet F., Dublet B., Andrieu J.P., Gaboriaud C., Arlaud G.J., Thielens N.M. The two major oligomeric forms of human mannan-binding lectin: chemical characterization, carbohydrate-binding properties, and interaction with MBL-associated serine proteases. Journal of Immunology 2005, 174:2870-2877.
41. Teillet F., Lacroix M., Thiel S., Weilguny D., Agger T., Arlaud G.J., Thielens N.M. Identification of the site of human mannan-binding lectin involved in the interaction with its partner serine proteases: the essential role of Lys55. Journal of Immunology 2007, 178:5710-5716.
42. Teillet F., Gaboriaud C., Lacroix M., Martin L., Arlaud G.J., Thielens N.M. Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins. Journal of Biological Chemistry 2008, 283:25715-25724.
43. Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W., Laursen S.B., Poulsen K., Willis A.C., Eggleton P., Hansen S., Holmskov U., Reid K.B., Jensenius J.C. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997, 386:506-510.
44. Thielens N.M., Cseh S., Thiel S., Vorup-jensen T., Rossi V., Jensenius J.C., Arlaud G.J. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and-2, MBL-associated protein 19, and MBL. Journal of Immunology 2001, 166:5068-5077.
45. Tran C.T., Kjeldsen K., Haunsø S., Høiby N., Johansen H.K., Christiansen M. Mannan binding lectin is a determinant of survival in infective endocarditis. Clinical and Experimental Immunology 2007, 148:101-105.
46. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunology Today 1996, 17:532-540.
47. Valdimarsson H., Vikingsdottir T., Bang P., Saevarsdottir S., Gudjonsson J.E., Oskarsson O., Christiansen M., Blou L., Laursen I., Koch C. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scandinavian Journal of Immunology 2004, 59:97-102.
48. Vorup-Jensen T., Petersen S.V., Hansen A.G., Poulsen K., Schwaeble W., Sim R.B., Reid K.B., Davis S.J., Thiel S., Jensenius J.C. Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. Journal of Immunology 2000, 165:2093-2100.
49. Wallis R., Shaw J.M., Uitdehaag J., Chen C.B., Torgersen D., Drickamer K. Localization of the serine protease-binding sites in the collagen-like domain of mannose-binding protein: indirect effects of naturally occurring mutations on protease binding and activation. Journal of Biological Chemistry 2004, 279:14065-14073.
50. Zundel S., Cseh S., Lacroix M., Dahl M.R., Matsushita M., Andrieu J.P., Schwaeble W.J., Jensenius J.C., Fujita T., Arlaud G.J., Thielens N.M. Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2. Journal of Immunology 2004, 172:4342-4350.